Gujarat Themis Biosyn Limited has expanded its global footprint by incorporating a wholly owned subsidiary in Japan. The new entity, named Themis Biosyn Japan Limited, was established on May 19, 2026. This strategic move marks the company's entry into the Japanese market, aligning with its broader business objectives.

Subsidiary Details

The incorporation of Themis Biosyn Japan Limited was completed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The subsidiary is fully owned by Gujarat Themis Biosyn Limited , which holds 100% of its shareholding.

Financial and Operational Information

The newly formed subsidiary has a share capital of Ten Lakhs Yen. As it is a recently incorporated entity, its turnover is currently not applicable. The subsidiary will operate within the pharmaceutical industry, consistent with the parent company's core business sector.

Key Particulars of the Subsidiary

The company has confirmed that no specific governmental or regulatory approvals were required for this incorporation. The business registration extract for the new entity is expected to be received at a later date.

Gujarat Themis Biosyn Limited has issued a notice to its members regarding a postal ballot to seek approval for special resolutions concerning the company's financial operations. The notice, dated 5th May 2026, outlines the company's intention to secure shareholder consent through remote electronic voting only, adhering to the provisions of the Companies Act, 2013, and relevant SEBI regulations.

Special Resolutions

The company is seeking member approval for two key special resolutions. The first resolution aims to approve an increase in the borrowing limits of the company under Section 180(1)(c) and the creation of a mortgage or charge on the company's assets, properties, or undertakings under Section 180(1)(a) of the Companies Act, 2013. The second resolution seeks approval for limits to give loans, guarantees, or investments, or provide security in connection with loans made to any person or body corporate. It also covers acquiring securities of any other body corporate in excess of the limits prescribed in Section 186 of the Companies Act, 2013.

E-Voting Schedule and Process

Central Depository Services (India) Limited (CDSL) has been engaged to provide the e-voting facility. The remote e-voting period is set to commence on Wednesday, 6th May 2026, at 9:00 a.m. IST and will conclude on Thursday, 4th June 2026, at 5:00 p.m. IST. Voting rights will be reckoned based on the paid-up value of equity shares registered as of the cut-off date, Friday, 1st May 2026.

Scrutiny and Results

The Board of Directors has appointed Mr. Ketan R. Shirwadkar, Proprietor of M/s. KRS AND CO., as the Scrutinizer to oversee the e-voting process. Following the scrutiny, the Chairman or an authorized person will announce the results within two working days, i.e., by Monday, 8th June 2026. The results, along with the Scrutinizer's Report, will be published on the company's website and the CDSL portal, and subsequently forwarded to the BSE and NSE stock exchanges.

Communication and Grievances

In compliance with Ministry of Corporate Affairs (MCA) circulars, no physical copies of the notice will be dispatched. The Postal Ballot Notice was emailed to members on 5th May 2026. Members who have not registered their email addresses can do so temporarily through the Registrar and Transfer Agent's link. The notice and explanatory statements are also available on the company's website and the websites of BSE, NSE, and CDSL. Any grievances related to e-voting may be addressed to Mr. Rakesh Dalvi, Sr. Manager at CDSL.